Study aims to Fine-Tune antibiotic dosing for ICU patients
NCT ID NCT07681544
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study looks at how the antibiotic meropenem behaves in the blood of critically ill adults in the intensive care unit. Researchers compare different doses (1 gram vs. 2 grams) and infusion times (30 minutes vs. 3 hours) to see which keeps drug levels above the needed threshold longer. Participants receive meropenem as part of standard care and provide blood samples during the first 48 hours. The goal is to help doctors choose the best dosing strategy for treating infections before the exact bacteria are known.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
meropenem
What this could lead to
If successful, this study could help doctors choose the best meropenem dose and infusion method for critically ill patients, potentially improving infection treatment.
What could go wrong
This is a small observational study with only 26 participants, so results may not apply to all patients. It does not test a new drug or directly measure patient outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICALLY ILL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Eleveld Model Dosing for Remimazolam Anesthesia NCT07675850
- Tracheal Suction During Extubation Study | NCT03681626
- Vancomycin Dosing in Obesity Study | NCT06601257
- Comparing Two Insulin Formulations in Healthy Me NCT07608692
- Critical Illness Risk Factors Study | NCT04502511
- Insulin Aspart Biosimilar Study in Healthy Volun NCT07600944
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina